The new Medical Device Regulation (MDR) which becomes fully applicable on May 26, 2021 is initiated to improve patient safety, to increase transparency and traceability but also to bring EU legislation in line with technical advances and create a fair market access for manufacturers.

In the third session in our MDR seminar series, Dr Tina Amini walks you through the details of the impact of EU MDR on Drug/Device Combination Products (DDCs).

Author

Tina Amini

LET’S TALK

You don't have to go it alone!

Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.

Building Better Biotechs

This field is for validation purposes and should be left unchanged.